GlobeNewswire

Father’s personal experience drives hospitals to improve patient communication

Del

CareCircle fills gap after CarePages closure leaves hospitals in a bind

GRAND RAPIDS, Mich., Sept. 18, 2018 (GLOBE NEWSWIRE) -- After experiencing the challenges that come with communicating with friends and family from during his daughter's chemotherapy treatment for a rare disease, Nathan Loding, 34, of Grand Rapids thought there had to be a better way to keep friends and family updated on his daughter’s condition and get the support their family needed.

Thanks to his livelihood as a software developer at Grand Rapids-based global business technology firm OST, he quickly turned his idea into reality.

The result is CareCircle (www.carecircle.com), a secure website that allows patients to safely provide updates on their health and share private information with a select audience. The site launched Sept. 1 and has already been piloted by one of the nation’s largest health care systems.

The platform is wholly-owned and operated by OST.

CareCircle’s launch is very timely, as popular patient communication website CarePages shuttered its operations in late 2017 and has left many health systems scrambling to identify a safe, reliable, solution.

“When my daughter started treatment, we struggled with communicating updates to family and friends. The existing platforms either lacked the privacy or functionality we needed,” said Loding. “I knew there was a better way and that OST was uniquely positioned to make it a reality. That's how the idea for CareCircle was born."

CareCircle works with health systems to offer a ‘plug-and-play’ patient experience tool that can be branded for that health system.

The service is a subscription-based, so hospitals work with OST to build and brand the website to their needs. The platform has already been tested at a major Midwest health system, paving the way for the provider to rollout to patients later this year.

With a nationally-recognized hospital system soon to announce its use of CareCircle, OST leaders expect others to sign up to offer for patient use.

“Nathan’s firsthand experience, coupled with OST’s 20 years of experience in health care information technology helps customers understand that this is a patient-centered solution,” said Laura Vaughn, product owner, OST. “We’re confident that CareCircle fills a void for health systems looking to expand their patient experience into the digital space.”

CareCircle hits the market at a unique time, as secure, private patient communication products are hard to come by, and health research has indicated that these platforms contribute to the well-being and healing of patients.

Studies have shown that patients who build robust social relationships show an improvement in their quality of life and even an increased chance of survival.

"When patients need support, they seek a safe space to talk openly about this sensitive time in their life," said Jim VanderMey, chief innovation officer, OST. "OST’s extensive health care industry experience has ensured that CareCircle is not only easy to use, but that it also works to protect the personal nature of a patient's health journey."

CareCircle is very easy for a patient or loved one to operate. Users simply log in to the health system’s CareCircle site and create a page. From there, the patient can begin sharing information and invite specific people to view the page. The platform is mobile and tablet-responsive as well.

About OST
www.ostusa.com
Founded in 1997, OST is an integrated, cross-functional business technology firm bringing together strategy & insights, digital experiences, connected products, data center transformation and enterprise managed services as they work alongside clients to optimize and grow their businesses. With offices located in Grand Rapids, Detroit, Minneapolis, London, Hong Kong and Singapore, OST and OpenDigital, the digital consultancy at OST, engage in ways that make the most sense and yield the best results for global Fortune 2000 companies to funded startups. This is all wrapped in a friendly, flexible, people-centered culture. OST has been recognized in Inc. Magazine’s 5,000’s Fastest Growing Private Companies, CRN’s Tech Elite 250, and as a National Best & Brightest Company to Work For. 

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/49089254-6574-492e-8b64-7e1585f417d7

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/88f03035-4460-4c67-b0c2-660b23a44892

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Infovista Expands 5G Network Testing and Planning Capabilities20.2.2019 15:00:00Pressemelding

ASHBURN, Va., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Infovista, the leader in modern network performance, today announced new versions of its TEMS Investigation and Planet solutions. With this announcement, Infovista is the only vendor offering the complete 5G portfolio comprising full network planning and testing in a single, integrated platform. Infovista is now uniquely positioned to help mobile network operators roll out 5G NR networks by including the ability to provide integrated Geodata, 5G Planning and Network Testing capabilities. Tweet This: @Infovista expands 5G network testing and planning capabilities, offering complete 5G portfolio in a single, integrated platform: https://bit.ly/2Nm8Rup With the new release of TEMS Investigation, Infovista introduces support for 5G smartphones based on the Qualcomm X50 chipset. With initial support of Qualcomm based devices and plans for agnostic device support, customers will be able to choose between different test devices and scanners to s

Reminder: Constellation Brands to Present at Consumer Analyst Group of New York Conference, February 20, 201920.2.2019 14:30:00Pressemelding

VICTOR, N.Y., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, reiterates that Bill Newlands, president and chief operating officer, and David Klein, chief financial officer, will present at the Consumer Analyst Group of New York (CAGNY) conference on Wednesday, February 20, 2019, at the Boca Raton Resort & Club in Florida. The presentation is scheduled to begin at 3:00 p.m. EST and is expected to cover the company’s strategic business activities, including a discussion on portfolio strategy; financial and operational performance; and outlook for the future, including a discussion on the accounting methodology and potential impact on fourth quarter fiscal year 2019 non-cash equity in earnings from the company’s Canopy Growth investment. A live audio webcast of the presentation can be accessed on the company’s website at www.cbrands.com by following the instructions in the “Investors” section under “Events & Presenta

Fortuna provides construction update at its Lindero gold project in Argentina20.2.2019 11:00:00Pressemelding

VANCOUVER, British Columbia, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to provide an update on construction activities at its 100 percent owned Lindero gold Project located in the Province of Salta, Argentina. Following the cessation of unusually heavy rainfall in Salta Province in recent weeks, which resulted in damage to the road leading to the Lindero Project site (see Fortuna news release dated February 7, 2019), management is pleased to report that the road has been repaired and on February 18th the mobilization of personnel and materials to the project site resumed. Mr. Jorge A. Ganoza, President, CEO and Director, commented, “Abnormal rains and electrical thunder storms not seen in a decade in the region are impacting our construction activities and schedule projections. A large amount of the float in the construction schedule has been consumed due to a slow start and ramp-up in excavations at the leach pad and crushing plant,

DoubleVerify Acquires Digital Video Technology Company, Zentrick20.2.2019 09:00:00Pressemelding

Solving 30% breakage in video ad delivery NEW YORK and GHENT, Belgium, Feb. 20, 2019 (GLOBE NEWSWIRE) -- DoubleVerify, the leading independent provider of marketing measurement software and analytics, today announced that it has acquired Zentrick, a digital video technology company that provides middleware solutions to drive the seamless execution and performance of online video advertising for the world’s largest brands, platforms and publishers. The Zentrick engineering teams will continue to operate from offices in Ghent, Belgium. The transaction was completed as an all cash, all stock offer on February 15, 2019. Video advertising spend soared to $28 Billion in 2018. However, the ecosystem necessary to support the growth in video ad delivery has become highly fragmented. Today over 30% of video ads that are sold are unable to be delivered by publishers due to various forms of technical ‘breakage’ in the ad delivery chain – an issue that’s particularly acute in the key areas of mobil

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma20.2.2019 07:00:00Pressemelding

Combination trial to evaluate safety and anti-tumor activity of agents that target B-cell cancers LAUSANNE, Switzerland, Feb. 20, 2019 (GLOBE NEWSWIRE) -- ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that the first patient has been dosed in a Phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumor activity of ADCT-402 (loncastuximab tesirine) in combination with Pharmacyclics LLC’s ibrutinib in patients with advanced diffuse large B-cell lymphoma (DLBCL) or mantle cell lymphoma (MCL). ADCT-402, an ADC designed to target and kill CD19-expressing malignant B-cells, is also being evaluated in an ongoing pivotal Phase II clinical trial in patients with relapsed or refractory (R/R) DLBCL and a Phase I clinical trial in combination with IMFINZI® (durvalumab) in patients with multiple types of R/R non-Hodgkin lymphoma. Ibrutinib, a sma

RedAwning Opens Up New Office in Palma de Mallorca, Spain To Offer Industry-Leading Distribution, Marketing + Reservations Services to European Property Managers20.2.2019 02:30:00Pressemelding

New Jetstream Team Office To Support RedAwning Group’s Expansion in Europe and Provide Comprehensive Support For International Clients Emeryville, California, Feb. 19, 2019 (GLOBE NEWSWIRE) -- RedAwning, the world’s largest collection of vacation properties, today announced that it has opened up an office in ParcBit, Palma de Mallorca, Spain to service the RedAwning Group’s growing portfolio of international vacation property managers and to offer RedAwning’s industry-leading distribution, marketing and reservation solutions to managers of alternative accommodations throughout Europe. RedAwning is a single point of entry for managers of single vacation homes and multi-unit boutique hotels, resorts, apart-hotels and corporate apartments to access the widest online travel network in the world, including Booking.com, Expedia, Airbnb, and HomeAway/VRBO, as well as a major travel metasearch sites including trivago, Holidu, HomeToGo and TripAdvisor. RedAwning is also integrated with Google H